Purchase Order 75N93024P01115
Award Date
9/9/24
Potential Completion Date
12/31/24
Potential Value
$23K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Irepertoire Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,271.70 firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Irepertoire Inc., a self-certified small disadvantaged business. The contract is for immune repertoire sequencing services, with a completion date of July 8, 2024. Irepertoire Inc. has previously provided similar services to various HHS and Department of Veterans Affairs (VA)...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Irepertoire Inc., a small disadvantaged business, for T-cell receptor sequencing services. The contract has a potential value of $19,404.00 and a completion date of July 26, 2024. Irepertoire Inc. has previously provided a range of services to HHS and other federal agencies, including T-cell receptor...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a small disadvantaged business, for RNA sequencing services for mouse T cell receptor research. The contract has a total ceiling value of $13,230.00 and a period of performance through February 28, 2025. Irepertoire Inc. will provide services such as T-cell receptor sequencing,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a self-certified small disadvantaged business. The $6,580 firm-fixed-price purchase order is for IPAIR Collaboration and Data Analysis Services, which likely involve T-cell receptor sequencing, RNA sequencing, PCR amplification, and related laboratory testing to support NIAID's research and...
Irepertoire Inc. was awarded a $19,620 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide T cell receptor deep sequencing services. The contract has a period of performance through May 10, 2024 and was awarded on January 11, 2024 without a set-aside designation. As part of its mission to understand, treat, and ultimately prevent infectious, immunologic, and allergic...
This is a $42,700 firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA) to Irepertoire Inc., a small disadvantaged business specializing in advanced molecular biology and immunological research services. The contract, which has no set-aside designation, is for VA NWI and University of Nebraska research. Irepertoire Inc. has a proven track record of securing federal research contracts from agencies such...
The Department of Veterans Affairs has awarded a Firm Fixed Price Definitive Contract worth $42,300.00 to Irepertoire Inc., a small disadvantaged business, to provide NWI RESEARCH - DR. MANON services. The contract has an ultimate completion date of August 31, 2024. Irepertoire Inc. is a for-profit organization that specializes in advanced molecular biology and immunological research services, with a focus on immune system analysis and sequencing technologies. The company has a strong track...
This is a $14,400.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Personal Diagnostix Inc., a minority-owned and small disadvantaged business, for Ion Torrent sequencing of RNA virus samples. The contract has an ultimate completion date of April 25, 2013 and does not have a set-aside designation. This contract appears to be for NIAID's research and development activities related to viral diagnostics...
The Centers for Disease Control and Prevention (CDC) awarded a $45,800 firm fixed price purchase order to Irepertoire Inc., a self-certified small disadvantaged business, to provide immune repertoire sequencing and analysis services. The purpose of the contract is to identify immune repertoire biomarkers for diagnosing and subclassifying Chronic Fatigue Syndrome (CFS) patients. This sole source award was made without a set-aside designation. Irepertoire Inc. specializes in T-cell receptor...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...